Tag Archives: Allergan

Feds Chase Down Faulty Skincare Promos

By George Koroneos | Published: August 26, 2009

FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims. J&J received a violation letter in response to a journal ad for its [...]

Posted in FDA, Marketing | Also tagged Advertising, Clinical trial, Johnson & Johnson, U.S. Food and Drug Administration | 1 Comment

Advanstar Corporate Site

Home | Contact Us | Advertise | Classifieds | What's New | All Content | Privacy Policy | Terms of Use | Linking and RSS Policy
© 2009 Advanstar Communications, Inc. All rights reserved.
Reproduction in whole or in part is prohibited.
Please send any technical comments or questions to our webmaster.

Powered by WordPress. Built on the Thematic Theme Framework.